Home › Trial NCT03761901
Study to Describe Treatment Patterns and Outcomes in EGFRm NSCLC Patients in Belgium
- Trial IDNCT03761901
- StatusCompleted
- PhaseN/A
- Study typeObservational
- SponsorAstraZeneca
- Enrollment141
- Start date2018-09-21
- ConditionsCarcinoma, Non-Small-Cell Lung
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.